Harvard Bioscience
HBIO
#10472
Rank
A$50.38 M
Marketcap
A$11.07
Share price
0.38%
Change (1 day)
1,348.40%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2026 (TTM): -A$14.71 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are A$85.53 Million. In 2025 the company made an earning of -A$80.1 Million a decrease over its 2024 earnings that were of -A$16.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$14.71 Million-81.64%
2025 -A$80.1 Million391.95%
2024 -A$16.29 Million356.38%
2023 -A$3.57 Million-72.15%
2022 -A$12.82 Million6456.43%
2021 -A$0.2 Million-98.08%
2020 -A$10.18 Million32.53%
2019 -A$7.68 Million-31.01%
2018 -A$11.14 Million243.9%
2017 -A$3.24 Million-24.66%
2016 -A$4.3 Million-14.69%
2015 -A$5.04 Million-181.68%
2014 A$6.16 M-9.97%
2013 A$6.84 M120%
2012 A$3.11 M-50.9%
2011 A$6.33 M-52.51%
2010 A$13.34 M-2.53%
2009 A$13.69 M28.26%
2008 A$10.67 M-20.05%
2007 A$13.35 M13.96%
2006 A$11.71 M17.59%
2005 A$9.96 M57.37%
2004 A$6.33 M-37.31%
2003 A$10.1 M208.03%
2002 A$3.27 M-168.71%
2001 -A$4.78 Million-66.89%
2000 -A$14.42 Million